XML 35 R21.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Note 15 - Revenue by Product Group, by Significant Customer and by Geographic Location; Geographic Information | 12 Months Ended
--- | ---
Dec. 31, 2017
Notes to Financial Statements |
Segment Reporting Disclosure [Text Block] | 15. Revenue by Product Group, by Significant Customer and by Geographic Location; Geographic Information Product revenue by product group is as follows:
|  | Years Ended December 31,
|  | 2017 |  | 2016 |  | 2015
|  | Revenue |  | Percentage of Product Revenue |  | Revenue |  | Percentage of Product Revenue |  | Revenue |  | Percentage of Product Revenue
Orthobiologics |  | $ | 93,816 |  |  |  | 87 | % |  | $ | 89,695 |  |  |  | 87 | % |  | $ | 73,247 |  |  |  | 84 | %
Dermal |  |  | 2,755 |  |  |  | 3 | % |  |  | 2,759 |  |  |  | 3 | % |  |  | 2,266 |  |  |  | 2 | %
Surgical |  |  | 5,262 |  |  |  | 5 | % |  |  | 5,427 |  |  |  | 5 | % |  |  | 5,812 |  |  |  | 7 | %
Other |  |  | 5,950 |  |  |  | 5 | % |  |  | 5,051 |  |  |  | 5 | % |  |  | 6,371 |  |  |  | 7 | %
|  | $ | 107,783 |  |  |  | 100 | % |  | $ | 102,932 |  |  |  | 100 | % |  | $ | 87,696 |  |  |  | 100 | %
Product revenue from our sole significant customer, Mitek, as a percentage of our total product revenue was 73%, 75%, and 72% for the years ended December 31, 2017, 2016, and 2015, respectively. ORTHOVISC became available for sale in the United States on March 1, 2004, and it is marketed exclusively by Mitek under the terms of an initial ten -year licensing, distribution, supply, and marketing agreement entered into in December 2003. The agreement was extended by Mitek for additional five -year terms in 2012 and in 2017, with the current agreement to expire on December 20, 2023. In December 2011, the Company entered into a fifteen -year licensing agreement with Mitek to exclusively market MONOVISC in the United States. The agreement provides certain milestone payments to the Company when rolling end-user sales of U.S. MONOVISC exceed certain target sales goals. For the years ended December 31, 2017, 2016, and 2015, the Company recognized milestone revenue of $5.0 million, $0.0 million, and $5.0 million, respectively, as a result of MONOVISC achieving end-user sales in 2015 of $50 million within a consecutive 12 -month period, and end-user sales in 2017 of $100 million within a consecutive 12 -month period. Under the terms of the agreement, there are additional milestone revenue that may be achieved in future years. Total revenue by geographic location based on the location of the customer in total and as a percentage of total revenue are as follows:
|  | Years Ended December 31,
|  | 2017 |  | 2016 |  | 2015
|  | Total |  | Percentage of |  | Total |  | Percentage of |  | Total |  | Percentage of
|  | Revenue |  | Revenue |  | Revenue |  | Revenue |  | Revenue |  | Revenue
Geographic Location: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
United States |  | $ | 92,905 |  |  |  | 82 | % |  | $ | 83,972 |  |  |  | 81 | % |  | $ | 76,621 |  |  |  | 82 | %
Europe |  |  | 12,435 |  |  |  | 11 | % |  |  | 10,953 |  |  |  | 11 | % |  |  | 8,756 |  |  |  | 9 | %
Other |  |  | 8,080 |  |  |  | 7 | % |  |  | 8,454 |  |  |  | 8 | % |  |  | 7,622 |  |  |  | 9 | %
Total |  | $ | 113,420 |  |  |  | 100 | % |  | $ | 103,379 |  |  |  | 100 | % |  | $ | 92,999 |  |  |  | 100 | %
The Company recorded licensing, milestone, and contract revenue of $5.6 million, $0.4 million, and $5.3 million for the years ended December 31, 2017, 2016, and 2015, respectively; substantially all was derived in the United States with the exception of 2016 which was derived in the Middle East and Latin America. Net long-lived assets, consisting of net property and equipment, are subject to geographic risks because they are generally difficult to move and to effectively utilize in another geographic area in a reasonable time period and because they are relatively illiquid. Net tangible long-lived assets by principal geographic areas are as follows:
|  | Years Ended December 31,
|  | 2017 |  | 2016
United States |  | $ | 52,828 |  |  | $ | 49,140 |
Italy |  |  | 3,355 |  |  |  | 3,156 |
Total |  | $ | 56,183 |  |  | $ | 52,296 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration